| 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist F Gasparini, K Lingenhöhl, N Stoehr, PJ Flor, M Heinrich, I Vranesic, ... Neuropharmacology 38 (10), 1493-1503, 1999 | 856 | 1999 |
| Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes LE Chavez-Noriega, JH Crona, MS Washburn, A Urrutia, KJ Elliott, ... Journal of Pharmacology and Experimental Therapeutics 280 (1), 346-356, 1997 | 518 | 1997 |
| Functional consequences of mutations in the human α1A calcium channel subunit linked to familial hemiplegic migraine M Hans, S Luvisetto, ME Williams, M Spagnolo, A Urrutia, A Tottene, ... Journal of Neuroscience 19 (5), 1610-1619, 1999 | 331 | 1999 |
| Structure and functional characterization of neuronal alpha 1E calcium channel subtypes. ME Williams, LM Marubio, CR Deal, M Hans, PF Brust, LH Philipson, ... Journal of Biological Chemistry 269 (35), 22347-22357, 1994 | 330 | 1994 |
| SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5 MA Varney, NDP Cosford, C Jachec, SP Rao, A Sacaan, FF Lin, ... Journal of Pharmacology and Experimental Therapeutics 290 (1), 170-181, 1999 | 237 | 1999 |
| Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function: I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain K Walker, M Bowes, M Panesar, A Davis, C Gentry, A Kesingland, ... Neuropharmacology 40 (1), 1-9, 2001 | 208 | 2001 |
| (R, S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo F Gasparini, V Bruno, G Battaglia, S Lukic, T Leonhardt, W Inderbitzin, ... Journal of Pharmacology and Experimental Therapeutics 289 (3), 1678-1687, 1999 | 194 | 1999 |
| Cyclic GMP is involved in the excitation of invertebrate photoreceptors EC Johnson, PR Robinson, JE Lisman Nature 324 (6096), 468-470, 1986 | 162 | 1986 |
| Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade M Jonsson, D Gurley, M Dabrowski, O Larsson, EC Johnson, LI Eriksson The Journal of the American Society of Anesthesiologists 105 (3), 521-533, 2006 | 138 | 2006 |
| Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5 LP Daggett, AI Sacaan, M Akong, SP Rao, SD Hess, C Liaw, A Urrutia, ... Neuropharmacology 34 (8), 871-886, 1995 | 138 | 1995 |
| Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly PF Brust, S Simerson, AF McCue, CR Deal, S Schoonmaker, ME Williams, ... Neuropharmacology 32 (11), 1089-1102, 1993 | 133 | 1993 |
| Comparative structure of human neuronal α2–α7 and β2–β4 nicotinic acetylcholine receptor subunits and functional expression of the α2, α3, α4, α7, β2, and β4 subunits KJ Elliott, SB Ellis, KJ Berckhan, A Urrutia, LE Chavez-Noriega, ... Journal of Molecular Neuroscience 7, 217-228, 1996 | 132 | 1996 |
| Light-dependent channels from excised patches of Limulus ventral photoreceptors are opened by cGMP. J Bacigalupo, EC Johnson, C Vergara, JE Lisman Proceedings of the National Academy of Sciences 88 (18), 7938-7942, 1991 | 124 | 1991 |
| Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes S Sydserff, EJ Sutton, D Song, MC Quirk, C Maciag, C Li, G Jonak, ... Biochemical pharmacology 78 (7), 880-888, 2009 | 118 | 2009 |
| Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and α4β4 stably expressed in HEK293 cells KA Stauderman, LS Mahaffy, M Akong, G Veliçelebi, LE Chavez-Noriega, ... Journal of Pharmacology and Experimental Therapeutics 284 (2), 777-789, 1998 | 109 | 1998 |
| Electrophysiological study of Drosophila rhodopsin mutants. EC Johnson, WL Pak The Journal of general physiology 88 (5), 651-673, 1986 | 102 | 1986 |
| Structural elements in domain IV that influence biophysical and pharmacological properties of human α1A-containing high-voltage-activated calcium channels M Hans, A Urrutia, C Deal, PF Brust, K Stauderman, SB Ellis, MM Harpold, ... Biophysical journal 76 (3), 1384-1400, 1999 | 99 | 1999 |
| Characterization of the recombinant human neuronal nicotinic acetylcholine receptors α3β2 and α4β2 stably expressed in HEK293 cells LE Chavez-Noriega, A Gillespie, KA Stauderman, JH Crona, BON Claeps, ... Neuropharmacology 39 (13), 2543-2560, 2000 | 97 | 2000 |
| Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine M Jonsson, M Dabrowski, DA Gurley, O Larsson, EC Johnson, ... The Journal of the American Society of Anesthesiologists 104 (4), 724-733, 2006 | 90 | 2006 |
| The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents GK Lloyd, F Menzaghi, B Bontempi, C Suto, R Siegel, M Akong, ... Life sciences 62 (17-18), 1601-1606, 1998 | 81 | 1998 |
